A randomized, phase III trial exploring the effects of neoadjuvant sequential treatment with steroidal (exemestane) and nonsteroidal (anastrozole) aromatase inhibitors on biomarkers in postmenopausal women with hormone receptor-positive locally advanced breast cancer

Podobne zapisy

• Regulation of aromatase expression in breast cancer treated with anastrozole neoadjuvant therapy
  od: GHIMENTI, CHIARA, i wsp.
  Wydane: (2013)
• Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action
  od: Cairns, Junmei, i wsp.
  Wydane: (2020)
• Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer
  od: Iaffaioli, R V, i wsp.
  Wydane: (2005)
• Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer
  od: Iaffaioli, R V, i wsp.
  Wydane: (2005)
• Efficacy of Exemestane in Korean Patients with Metastatic Breast Cancer after Failure of Nonsteroidal Aromatase Inhibitors
  od: Lee, June Koo, i wsp.
  Wydane: (2013)